| Literature DB >> 33349310 |
Maryam Shakiba, Maryam Nazemipour, Arsalan Salari, Fardin Mehrabian, Seyed Saeed H Nazari, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Mohammad Ali Mansournia.
Abstract
We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).Entities:
Keywords: COVID-19; Guilan; Iran; SARS-CoV-2; asymptomatic infections; coronavirus disease; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses
Mesh:
Substances:
Year: 2020 PMID: 33349310 DOI: 10.3201/eid2702.201960
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883